Dexcel Pharma Technologies Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 4,848,484 shares at $8.25 ($40.0M) on 2019-06-04, disclosed to the SEC on 2019-06-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.25 | 2,424,242 | $20.0M | 50.0% |
| 2 | $8.25 | 2,424,242 | $20.0M | 50.0% |
| Total | $8.25 avg | 4,848,484 | $40.0M | 100% |
| Filing → |
| UROV | BUY | 2019-06-19 | $262K | — | Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |